K2 THERAPEUTICS
Live / Registered — Registered (as of 08 Sept 2026)
What this means for you
Registered since 08 Sept 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99975512
- Registration number
- 8199452
- Mark type
- Stylized text
- Filed
- 28 Feb 2025
- Published for opposition
- 09 Sept 2025
- Registered
- 08 Sept 2026
- Attorney of record
- Kristin H. Altoff, Esq.
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific research and development; medical research; development in the field of medical products and preparations; medical research, development, manufacturing and commercialization services in the fields of drug discovery, oncology, auto-immunity and immunology; development of manufacturing methods for others for pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology
Owner
- K2 Therapeutics Pte. Ltd., Republic Plaza, SG
- K2 Therapeutics Pte. Ltd., Republic Plaza, SG
- K2 Therapeutics Pte. Ltd., Republic Plaza, SG
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Apr 2026 — USE AMENDMENT FILED
- 22 Jul 2026 — DIVISIONAL PROCESSING COMPLETE
- 15 Apr 2026 — DIVISIONAL REQUEST RECEIVED
- 15 Apr 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Apr 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION